{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:40:02Z","timestamp":1771540802496,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/ico.0000000000000037","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T13:27:04Z","timestamp":1386768424000},"page":"154-160","source":"Crossref","is-referenced-by-count":31,"title":["Bevacizumab in the Treatment of Pterygium"],"prefix":"10.1097","volume":"33","author":[{"given":"Qiongwen","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210204","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0161-6420(97)30224-3","article-title":". Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial.","volume":"104","author":"Manning","year":"1997","journal-title":"Ophthalmology"},{"key":"R2-10-20210204","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/ijmm_00000149","article-title":"Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review).","volume":"23","author":"Detorakis","year":"2009","journal-title":"Int J Mol Med"},{"key":"R3-10-20210204","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/02713680802045099","article-title":". Extensive versus limited pterygium excision with conjunctival autograft: outcomes and recurrence rates.","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"R4-10-20210204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1542-0124(12)70287-2","article-title":"Pterygium: its treatment with beta therapy.","volume":"7","author":"Murube","year":"2009","journal-title":"Ocul Surf"},{"key":"R5-10-20210204","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ophtha.2012.06.066","article-title":". Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.","volume":"120","author":"Kaufman","year":"2013","journal-title":"Ophthalmology"},{"key":"R6-10-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14740338.6.1.27","article-title":"Uses and complications of mitomycin C in ophthalmology.","volume":"6","author":"Mearza","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"R7-10-20210204","first-page":"1849","article-title":"The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium.","volume":"6","author":"Kareem","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R8-10-20210204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10792-011-9509-x","article-title":". 5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence.","volume":"32","author":"Bekibele","year":"2012","journal-title":"Int Ophthalmol"},{"key":"R9-10-20210204","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2007.01.047","article-title":"Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia.","volume":"69","author":"Hosseini","year":"2007","journal-title":"Med Hypotheses"},{"key":"R10-10-20210204","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":". Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia.","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"key":"R11-10-20210204","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.eye.6702495","article-title":". Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.","volume":"21","author":"Aspiotis","year":"2007","journal-title":"Eye (Lond)"},{"key":"R12-10-20210204","first-page":"1963","article-title":"Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis.","volume":"42","author":"Di Girolamo","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-10-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ICO.0b013e3181822615","article-title":". Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.","volume":"28","author":"Wu","year":"2009","journal-title":"Cornea"},{"key":"R14-10-20210204","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/ICU.0b013e3283548459","article-title":". Anterior segment uses of bevacizumab.","volume":"23","author":"Bahar","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"R15-10-20210204","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"; Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaborations tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R16-10-20210204","first-page":"1","article-title":"Carroll D, et al..","volume":"17","author":"Jadad","year":"1996","journal-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary Control Clin Trials"},{"key":"R17-10-20210204","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0161-6420(97)30197-3","article-title":". Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.","volume":"104","author":"Prabhasawat","year":"1997","journal-title":"Ophthalmology"},{"key":"R18-10-20210204","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000252980","article-title":". Preliminary results of subconjunctival bevacizumab in primary pterygium excision.","volume":"43","author":"Razeghinejad","year":"2010","journal-title":"Ophthalmic Res"},{"key":"R19-10-20210204","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/ICO.0b013e31820ca63f","article-title":". Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.","volume":"30","author":"Shenasi","year":"2011","journal-title":"Cornea"},{"key":"R20-10-20210204","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/ICO.0b013e3182772d4e","article-title":". Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.","volume":"32","author":"Ozgurhan","year":"2013","journal-title":"Cornea"},{"key":"R22-10-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ICO.0b013e3182151e0e","article-title":". Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.","volume":"31","author":"Lekhanont","year":"2012","journal-title":"Cornea"},{"key":"R23-10-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":". Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"key":"R24-10-20210204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3928\/15428877-20120802-02","article-title":"Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report.","volume":"43","author":"Shahin","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R25-10-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jop.2010.0094","article-title":". Bevacizumab and ocular wound healing after primary pterygium excision.","volume":"27","author":"Banifatemi","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"R26-10-20210204","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/ICO.0b013e31821c9b44","article-title":". A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.","volume":"30","author":"Enkvetchakul","year":"2011","journal-title":"Cornea"},{"key":"R27-10-20210204","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R28-10-20210204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0039-6257(02)00463-0","article-title":"The treatment of pterygium.","volume":"48","author":"Hirst","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"R29-10-20210204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":". Intracameral bevacizumab for iris rubeosis.","volume":"142","author":"Grisanti","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R30-10-20210204","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":". Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.","volume":"146","author":"Krohne","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R31-10-20210204","first-page":"841","article-title":"Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.","volume":"5","author":"Marey","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R32-10-20210204","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ophtha.2010.10.033","article-title":"Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis.","volume":"118","author":"Pan","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000000037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:08:07Z","timestamp":1620954487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201402000-00010"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000000037","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}